Jazz Pharmaceuticals (JAZZ) Operating Income (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) reported Operating Income of $248.2 million for Q2 2026, compared with -$686.4 million a year earlier and down 26.3% from the prior quarter.
Powered by 
Analysis
Jazz Pharmaceuticals (JAZZ) Operating Income (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Jazz Pharmaceuticals' Operating Income came in at $896.84 million; for FY2025, it was -$430.24 million.
- By year, Operating Income came in at $716.63 million in FY2024 (+23.9%), $578.58 million in FY2023, -$65.53 million in FY2022 and $170.28 million in FY2021 (-55.0%).
- Five-year quarterly Operating Income spans a low of -$686.4 million in Q2 2025 and a high of $336.6 million in Q1 2026.
- Year over year, Operating Income gained in three of the last four quarters, with growth averaging 15.6%.
- The high point for year-over-year Operating Income in five years was Q3 2023 (growth of 596.2%); the low point was Q3 2021 (a decline of 85.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $336.6 million (Q1 2026), $254.54 million (Q4 2025) and $57.51 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Jazz Pharmaceuticals | 15.08 Bn | 8.90 Bn | 1.09 Bn | 248.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 248.20 Mn |
| Mar 31, 2026 | 336.60 Mn |
| Dec 31, 2025 | 254.54 Mn |
| Sep 30, 2025 | 57.51 Mn |
| Jun 30, 2025 | -686.40 Mn |
| Mar 31, 2025 | -55.90 Mn |
| Dec 31, 2024 | 190.77 Mn |
| Sep 30, 2024 | 260.21 Mn |
| Jun 30, 2024 | 199.44 Mn |
| Mar 31, 2024 | 66.21 Mn |
| Dec 31, 2023 | 122.50 Mn |
| Sep 30, 2023 | 172.39 Mn |
| Jun 30, 2023 | 157.64 Mn |
| Mar 31, 2023 | 126.06 Mn |
| Dec 31, 2022 | -263.39 Mn |
| Sep 30, 2022 | 24.76 Mn |
| Jun 30, 2022 | 85.55 Mn |
| Mar 31, 2022 | 87.55 Mn |
| Dec 31, 2021 | 49.38 Mn |
| Sep 30, 2021 | 28.37 Mn |
API Access
Jazz Pharmaceuticals Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=JAZZ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "JAZZ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=JAZZ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();